Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
48.10
-0.31 (-0.64%)
Aug 24, 2026, 3:04 PM CST

Intco Medical Technology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
11,9219,9269,5236,9196,61416,240
Revenue Growth
20.12%4.23%37.65%4.61%-59.27%17.37%
Gross Profit
3,7962,3742,176942.35837.659,973
Operating Income
2,143909901.75-162.49-70.288,583
Net Income
1,1381,0111,465383629.077,430
Earnings Per Share
1.751.572.260.580.9511.00
EPS Growth
-29.42%-30.53%289.65%-38.95%-91.36%-2.73%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Personal Protection
8,8358,6006,1806,00515,807
Rehabilitation Nursing Category
447.87457.67395.79377.81254.73
Other
642.77465.51343.1230.95177.91
Total
9,9269,5236,9196,61416,240

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
15,13013,19118,75113,1818,2708,277
Total Debt
17,47917,50113,2697,1661,580292.05
Net Cash (Debt)
-2,349-4,3105,4826,0156,6897,985
Net Cash Growth
---8.86%-10.08%-16.23%30.68%
Net Cash Per Share
-3.62-6.698.459.1110.1011.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
2,8971,8851,079502.411,0658,680
Capital Expenditures
-1,908-2,575-1,789-1,439-1,715-5,444
Free Cash Flow
989.2-689.72-710.37-936.28-649.763,236
Free Cash Flow Growth
------43.12%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
31.84%23.91%22.85%13.62%12.67%61.41%
Operating Margin
17.97%9.16%9.47%-2.35%-1.06%52.85%
Pretax Margin
12.50%12.39%16.89%6.40%10.65%53.26%
Profit Margin
9.54%10.18%15.39%5.54%9.51%45.75%
FCF Margin
8.30%-6.95%-7.46%-13.53%-9.82%19.93%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1500.1500.1500.0800.0990.625
Dividend Per Share Growth
0%0%87.50%-19.00%-84.20%-66.25%
Dividend Yield
0.30%0.39%0.60%0.35%0.48%1.35%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
27.4324.9511.0740.0122.054.28
Forward PE
12.7415.8311.931.461.465.01
P/FCF Ratio
31.50----9.83
PS Ratio
2.612.541.702.222.101.96